Samsher S. Singh
CV Raman Avenue
Bengaluru, KA 560012, India
Bengaluru, KA 560012, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A Mycobacteria-Specific Prodrug to Overcome Phenotypic AMR in Mycobacterium tuberculosis.
Journal: Journal of medicinal chemistry
Published: December 01, 2025
5-(3, 4-methylenedioxyphenyl)-4-ethyl-2E, 4E-pentadienoic acid piperidide as MdeA efflux pump inhibitor of Staphylococcus aureus.
Journal: Biochimie
Published: March 16, 2025
An Arm-to-Disarm Strategy to Overcome Phenotypic AMR in Mycobacterium tuberculosis.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2024
Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.
Journal: Molecules (Basel, Switzerland)
Published: October 30, 2023
Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species.
Journal: Antimicrobial agents and chemotherapy
Published: August 17, 2022
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition.
Journal: Journal of medicinal chemistry
Published: January 04, 2022
Mevo lectin specificity toward high-mannose structures with terminal αMan(1,2)αMan residues and its implication to inhibition of the entry of Mycobacterium tuberculosis into macrophages.
Journal: Glycobiology
Published: November 13, 2020
Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
Journal: Bioorganic & medicinal chemistry
Published: August 11, 2018
Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
Journal: Pulmonary pharmacology & therapeutics
Published: August 20, 2017
Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and Intracellular Invasion of Bacteria.
Journal: Frontiers in microbiology
Published: July 05, 2017
Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.
Journal: Bioorganic & medicinal chemistry letters
Published: May 23, 2016
Last Updated: 09/26/2026